New direction of tumor immunotherapy

[SY6-2] Integrating anti-leukemia and anti-pathogen T-cell therapy in stem cell transplantation

David Gottlieb (Department of Medicine, Westmead Hospital, University of Sydney, Australia)

David Gottlieb is a bone marrow transplant physician with a major research interest is in cellular immunotherapy for the treatment of infection and malignancy in immunocompromised patients especially in allogeneic stem cell transplant recipients. His work focuses on adoptive immunotherapy for rapid reconstruction of the immune system following intensive therapy.
1980-1986 Medical officer, Westmead Hospital, Sydney.
1986-1990 Lecturer, Royal Free Hospital, London
1990-1999 Senior Lecturer, University of Sydney, Westmead Hospital, Sydney
1990- Physician BMT Service Westmead Hospital, Sydney
1990-2000 Visiting scholar Hospital San Raffaele, Milan, Italy
1997-2003 Associate Professor, University of Sydney, Westmead Hospital, Sydney
2003- Professor, University of Sydney, Westmead Hospital, Sydney
2003- Head Cell Therapies Unit, Westmead Hospital, Sydney
2004-2017 Medical Director Sydney Cellular Therapies Laboratory, Westmead Hospital, Sydney
2013- Program Director, BMT Service, Westmead Hospital Sydney